Janus Henderson Group’s Nektar Therapeutics NKTR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q2
Sell
-5,507
Closed -$57.8K 2644
2023
Q1
$57.8K Buy
5,507
+3,075
+126% +$32.3K ﹤0.01% 2654
2022
Q4
$82.3K Sell
2,432
-2,431
-50% -$82.2K ﹤0.01% 2364
2022
Q3
$234K Buy
4,863
+2,436
+100% +$117K ﹤0.01% 2327
2022
Q2
$138K Sell
2,427
-3
-0.1% -$171 ﹤0.01% 2413
2022
Q1
$196K Sell
2,430
-125
-5% -$10.1K ﹤0.01% 2448
2021
Q4
$518K Buy
2,555
+764
+43% +$155K ﹤0.01% 1871
2021
Q3
$482K Buy
+1,791
New +$482K ﹤0.01% 1634
2021
Q2
Sell
-3,922
Closed -$1.18M 1648
2021
Q1
$1.18M Buy
+3,922
New +$1.18M ﹤0.01% 1255
2020
Q4
Sell
-3,323
Closed -$827K 1411
2020
Q3
$827K Sell
3,323
-923
-22% -$230K ﹤0.01% 1162
2020
Q2
$1.48M Sell
4,246
-288
-6% -$100K ﹤0.01% 1073
2020
Q1
$1.21M Sell
4,534
-71,285
-94% -$19.1M ﹤0.01% 1076
2019
Q4
$24.5M Sell
75,819
-21,391
-22% -$6.93M 0.01% 775
2019
Q3
$26.6M Sell
97,210
-65,874
-40% -$18M 0.01% 760
2019
Q2
$87M Sell
163,084
-1,107
-0.7% -$591K 0.05% 416
2019
Q1
$82.8M Sell
164,191
-4,273
-3% -$2.15M 0.05% 445
2018
Q4
$83.1M Sell
168,464
-133,936
-44% -$66M 0.05% 404
2018
Q3
$277M Sell
302,400
-23,998
-7% -$21.9M 0.15% 176
2018
Q2
$239M Sell
326,398
-25,789
-7% -$18.9M 0.14% 195
2018
Q1
$561M Buy
352,187
+98,499
+39% +$157M 0.33% 67
2017
Q4
$227M Buy
253,688
+31,736
+14% +$28.4M 0.14% 192
2017
Q3
$79.9M Buy
221,952
+103,757
+88% +$37.4M 0.05% 403
2017
Q2
$34.7M Buy
+118,195
New +$34.7M 0.02% 613